Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine/Nab-paclitaxel, FOLFIRINOX, and Metformin in Advanced Pancreatic Cancer
NCT01488552Phase 2Completed
- Sponsor
- Pancreatic Cancer Research Team
- Start
- Nov 2011
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, liquid metformin (Aspargo Labs), sponsored by Pancreatic Cancer Research Team. Started Nov 2011; status: completed.
02
Drugs
paclitaxelliquid metformin (Aspargo Labs)
Beyond the preview
Go deeper on NCT01488552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01488552.